Nasdaq · Healthcare

ROCKWELL MEDICAL, INC. (RMTI)

As-reported financials and recent SEC filings for ROCKWELL MEDICAL, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$69.3M

Net income

$-5.3M

Net margin

-7.7%

Diluted EPS

$-0.15

ROE

-14.4%

P/E (TTM)

—

Market cap

—

Debt / equity

0.2×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$69.3M	$101.5M	$83.6M	$72.8M	$61.9M
Gross profit	$11.7M	$17.5M	$8.7M	$4.1M	$-2.4M
Operating income	$-4.7M	$608,000	$-6.7M	$-16.8M	$-30.3M
Net income	$-5.3M	$-480,000	$-8.4M	$-18.7M	$-32.7M
Diluted EPS	$-0.15	$-0.03	$-0.37	$-1.31	$-3.83

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-07-06

42026-07-06

42026-07-06

42026-07-06

42026-07-06

42026-07-06

42026-07-06

42026-07-06

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on RMTI

Search ROCKWELL MEDICAL, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.